All In MedTech

Device Trial Radar · NCT01270633

A Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers

A Multi-Center, Prospective, Randomized Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers

Last checked: Nov 19, 2026Latest source record: Dec 2, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

30

Actual

Start

Dec 2010

Primary completion

Sep 2017

Study completion Sep 2017

Sponsor

Lead sponsor
Integra LifeSciences CorporationPublic (IART)
Sponsor type
Industry
First posted
Jan 5, 2011

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the clinical and economic effectiveness of PriMatrix and Standard of Care in the treatment of diabetic foot ulcers (DFUs) in subjects with controlled diabetes mellitus and without significantly compromised arterial circulation.

Conditions

  • Foot Ulcer, Diabetic

Interventions

  • PriMatrixDevice

    Following sharp debridement, application of PriMatrix dermal repair scaffold in conjunction with moist wound therapy

  • Standard of CareOther

    Following sharp debridement, moist wound therapy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent of study ulcers healedTime frame: 12 weeks post-randomization

Locations

8 sites in 2 countries. Site status is shown where the registry gives one.

  • HyperbaRXs

    Cumming, Georgia

  • Covenant Medical Center

    Saginaw, Michigan

  • Professional Hospital

    Guaynabo, Puerto Rico

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.